Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.

Launched by FONDAZIONE IRCCS SAN GERARDO DEI TINTORI · Jan 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how to better diagnose and treat patients who experience delayed neurological problems after a type of brain hemorrhage known as aneurysmal subarachnoid hemorrhage (aSAH). Although many patients are surviving longer due to early treatment, some develop serious long-term issues with their brain function. The study aims to find out how often these delayed issues occur, how they can be identified early, and what treatments are most effective.

To participate in the trial, individuals must be at least 18 years old, have been diagnosed with aSAH from a ruptured brain aneurysm, and require care in an Intensive Care Unit. Participants will receive close monitoring and treatment strategies from various centers, helping researchers gather important information on outcomes related to their brain health over time. The trial is currently recruiting participants, and all eligible individuals are encouraged to consider taking part to help improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Primary diagnosis of subarachnoid hemorrhage due to rupture of a cerebral artery aneurysm confirmed by cerebral angiotomography or angiography of the intracranial vessels, with the need for admission to the Intensive Care Unit
• • Signing the Informed Consent form to participate in the study according to current local regulations.
• Exclusion Criteria:
• • Age \< 18 years
• • Primary diagnosis of subarachnoid hemorrhage sine materia, i.e. post-traumatic or caused by arteriovenous malformation or bleeding from a brain tumor.